US Patent Issued to Merck Sharp & Dohme on April 15 for "Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,729, issued on April 15, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors" was invented by Yongqi Deng (Newton, Mass.), Abdelghani Achab (Melrose, Mass.), David Jonathan Bennett (Winchester, Mass.), Indu Bharathan (Somerville, Mass.), Xavier Fradera (Boston), Craig Gibeau (Northborough, Mass.), Yongxin Han (Needham, Mass.), Derun Li (West Roxbury, Mass.), Kun Liu (Needham, Mass.), Qinglin Pu (Needham, Mass.), Sulagna Sanyal (Belmont, Mass.), David Sloman (Newton, Mass.), Wensheng Yu (Edison, N.J.) and Hongjun Zhang (Boston).

According to the abstract* released by the U.S. Patent & Trad...